Get the Stockscreener App
0.8079
0.06%
-0.0005
Pre-market:
.81
0.0021
+0.26%
Neumora Therapeutics Inc Stock (NMRA) Forecast
The Neumora Therapeutics Inc (NMRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.71, representing a +1,597% increase from the current price of $0.8079. The highest analyst price target is $16.47, and the lowest is $10.95.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NMRA Price Target
Average 10.64
(+1,217% Upside)
Is Neumora Therapeutics Inc (NMRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.77 | Neutral |
| STOCH(9,6) | 18.89 | Buy |
| STOCHRSI(14) | 6.3472 | Buy |
| MACD(12,26) | 0.0274 | Sell |
| ADX(14) | 27.30 | Buy |
| William %R | -81.86 | Buy |
| CCI(14) | -41.77 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9069
Sell
|
0.8529
Sell
|
| MA20 |
0.8176
Sell
|
0.8294
Sell
|
| MA50 |
0.7474
Buy
|
0.9569
Sell
|
| MA100 |
1.1098
Sell
|
2.0449
Sell
|
| MA200 |
5.8123
Sell
|
4.536
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, NMRA could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 10 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NMRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.77 indicates that NMRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.89 indicates that NMRA is oversold. This indicates that NMRA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.3472 indicates that NMRA is oversold. This suggests that NMRA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.3 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -41.77 indicates that NMRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NMRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neumora Therapeutics Inc financial reports and earnings history, Neumora Therapeutics Inc (NMRA) stock could reach $5.2318 by 2030, $23.85 by 2040 and $53.97 by 2050. See the projected annual prices until 2050 of the Neumora Therapeutics Inc stock below:
- Neumora Therapeutics Inc (NMRA) is expected to reach an average price of $7.2175 in 2035, with a high prediction of $7.1308 and a low estimate of $7.9874. This indicates an $793.36% rise from the last recorded price of $0.8079.
- Neumora Therapeutics Inc (NMRA) stock is projected to chart a bullish course in 2040, with an average price target of $22.80, representing an $2,722% surge from its current level. The forecast ranges from a conservative $23.45 to a sky-high $23.85.
- Our analysts predict Neumora Therapeutics Inc (NMRA) to jump 4,313% by 2045, soaring from $35.15 to an average price of $35.65, potentially reaching $36.64. While $35.15 is the low estimate, the potential upside is significant.
- Neumora Therapeutics Inc (NMRA) stock is expected to climb by 2050, reaching an average of $53.31, a $6,499% jump from its current level. However, a wide range of estimates exists, with high and low targets of $53.97 and $53.77, respectively, highlighting the market's uncertainty.
Neumora Therapeutics Inc Stock (NMRA) Year by Year Forecast
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2025
Neumora Therapeutics Inc Stock (NMRA) is expected to reach an average price of $10.64 in 2025, with a high prediction of $17.64 and a low estimate of $3.64. This indicates an +1,217% rise from the last recorded price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $14.23 | $10.95 | $16.47 | +1,662% |
| August, 2025 | $9.8832 | $9.6732 | $17.64 | +1,123% |
| September, 2025 | $6.9243 | $6.7043 | $11.68 | +757.08% |
| October, 2025 | $8.3467 | $4.11 | $10.59 | +933.13% |
| November, 2025 | $6.0133 | $3.64 | $9.0422 | +644.31% |
| December, 2025 | $6.3966 | $4.8233 | $7.1199 | +691.76% |
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2026
The predicted value for Neumora Therapeutics Inc (NMRA) in 2026 is set at an average of $8.8466. Estimates vary from a peak of $15.96 to a trough of $1.7366, indicating an +995.01% surge from the present price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.1933 | $4.5566 | $10.30 | +1,038% |
| February, 2026 | $9.0899 | $7.9499 | $13.91 | +1,025% |
| March, 2026 | $10.16 | $8.2516 | $11.16 | +1,157% |
| April, 2026 | $12.98 | $9.2242 | $14.75 | +1,507% |
| May, 2026 | $8.7865 | $7.2867 | $15.96 | +987.57% |
| June, 2026 | $4.2931 | $3.9631 | $10.04 | +431.39% |
| July, 2026 | $4.4911 | $2.18 | $8.66 | +455.90% |
| August, 2026 | $3.4133 | $1.7366 | $5.8177 | +322.49% |
| September, 2026 | $4.921 | $2.9644 | $5.6709 | +509.11% |
| October, 2026 | $10.31 | $2.7421 | $12.11 | +1,177% |
| November, 2026 | $7.2054 | $6.4904 | $11.35 | +791.87% |
| December, 2026 | $12.89 | $7.311 | $13.03 | +1,496% |
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neumora Therapeutics Inc (NMRA) is $7.221, with a high forecast of $14.28 and a low forecast of $0.1667. This indicates an +793.80% increase from the last price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.28 | $9.9354 | $14.28 | +1,296% |
| February, 2027 | $7.7475 | $5.6322 | $11.92 | +858.97% |
| March, 2027 | $5.3736 | $2.3442 | $8.4031 | +565.14% |
| April, 2027 | $0.3933 | $0.1667 | $6.73 | -51.32% |
| May, 2027 | $2.511 | $0.1722 | $3.9322 | +210.81% |
| June, 2027 | $3.2132 | $1.1055 | $3.8387 | +297.73% |
| July, 2027 | $8.111 | $0.9277 | $10.32 | +903.96% |
| August, 2027 | $6.6587 | $4.7293 | $8.6154 | +724.20% |
| September, 2027 | $10.74 | $5.773 | $11.32 | +1,229% |
| October, 2027 | $6.7286 | $5.0486 | $12.59 | +732.85% |
| November, 2027 | $5.3764 | $3.9777 | $6.7664 | +565.47% |
| December, 2027 | $0.55 | $0.7252 | $4.80 | -31.92% |
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2028
In 2028, Neumora Therapeutics Inc (NMRA) is projected to reach an average price of $5.5446, with a high projection of $10.91 and a low estimate of $0.1761. This indicates an +586.29% rise from the last price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8867 | $0.9468 | $3.3055 | +9.76% |
| February, 2028 | $0.4266 | $0.7467 | $2.0466 | -47.20% |
| March, 2028 | $1.6932 | $0.1761 | $2.0064 | +109.58% |
| April, 2028 | $5.2665 | $0.6765 | $8.5198 | +551.87% |
| May, 2028 | $4.9531 | $2.9681 | $5.9298 | +513.08% |
| June, 2028 | $7.4364 | $4.0474 | $9.5997 | +820.46% |
| July, 2028 | $3.2297 | $3.0197 | $10.91 | +299.76% |
| August, 2028 | $0.5637 | $0.1929 | $5.1296 | -30.22% |
| September, 2028 | $0.6622 | $0.6204 | $2.87 | -18.03% |
| October, 2028 | $1.529 | $2.859 | $1.6512 | +89.25% |
| November, 2028 | $0.9679 | $1.2279 | $1.2245 | +19.81% |
| December, 2028 | $1.9709 | $0.8935 | $3.0809 | +143.96% |
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2029
The 2029 price forecast for Neumora Therapeutics Inc Stock (NMRA) is $4.7058 on average, with a high prediction of $9.2319 and a low estimate of $0.1797. This represents an +482.47% increase from the previous price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.922 | $0.7631 | $6.7231 | +137.90% |
| February, 2029 | $6.3408 | $2.0542 | $6.4108 | +684.85% |
| March, 2029 | $6.2196 | $4.753 | $7.883 | +669.85% |
| April, 2029 | $2.1685 | $0.6687 | $9.2319 | +168.41% |
| May, 2029 | $2.1805 | $1.4349 | $3.4929 | +169.89% |
| June, 2029 | $3.1578 | $2.3083 | $1.7183 | +290.87% |
| July, 2029 | $4.0934 | $4.5134 | $3.5456 | +406.67% |
| August, 2029 | $2.4079 | $2.8579 | $3.0923 | +198.05% |
| September, 2029 | $3.1264 | $1.0336 | $4.9264 | +286.98% |
| October, 2029 | $1.4019 | $0.1797 | $4.1974 | +73.53% |
| November, 2029 | $6.0263 | $0.5962 | $6.1663 | +645.92% |
| December, 2029 | $4.5507 | $3.2108 | $7.5507 | +463.27% |
Neumora Therapeutics Inc Stock (NMRA) Price Forecast for 2030
Neumora Therapeutics Inc Stock (NMRA) is expected to reach an average price of $3.6832 in 2030, with a high forecast of $7.3345 and a low forecast of $0.0318. This signifies an +355.89% surge from the last price of $0.8079.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4662 | $0.0318 | $5.2318 | -42.30% |
| February, 2030 | $3.1911 | $3.0627 | $3.3194 | +294.99% |
| March, 2030 | $7.2201 | $6.6834 | $4.0014 | +793.68% |
| April, 2030 | $4.9601 | $6.3501 | $5.4401 | +513.95% |
| May, 2030 | $4.0802 | $4.5402 | $4.5301 | +405.04% |
| June, 2030 | $0.9597 | $0.6097 | $3.5302 | +18.79% |
| July, 2030 | $0.7904 | $0.5803 | $1.4997 | -2.17% |
| August, 2030 | $3.9096 | $1.1104 | $4.4496 | +383.92% |
| September, 2030 | $0.0395 | $1.5296 | $5.8695 | -95.11% |
| October, 2030 | $4.4706 | $1.2906 | $2.3006 | +453.36% |
| November, 2030 | $8.27 | $5.4506 | $4.9206 | +923.64% |
| December, 2030 | $8.4645 | $8.5957 | $7.3345 | +947.72% |
1.06%
1.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):